These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37709843)

  • 21. Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice.
    Nannenga B; Lu X; Dumble M; Van Maanen M; Nguyen TA; Sutton R; Kumar TR; Donehower LA
    Mol Carcinog; 2006 Aug; 45(8):594-604. PubMed ID: 16652371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responses.
    Uyanik B; Goloudina AR; Akbarali A; Grigorash BB; Petukhov AV; Singhal S; Eruslanov E; Chaloyard J; Lagorgette L; Hadi T; Baidyuk EV; Sakai H; Tessarollo L; Ryffel B; Mazur SJ; Lirussi F; Garrido C; Appella E; Demidov ON
    Nat Commun; 2021 Jun; 12(1):3622. PubMed ID: 34131120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1.
    Loizou E; Banito A; Livshits G; Ho YJ; Koche RP; Sánchez-Rivera FJ; Mayle A; Chen CC; Kinalis S; Bagger FO; Kastenhuber ER; Durham BH; Lowe SW
    Cancer Discov; 2019 Jul; 9(7):962-979. PubMed ID: 31068365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of PPM1D as an essential Ulk1 phosphatase for genotoxic stress-induced autophagy.
    Torii S; Yoshida T; Arakawa S; Honda S; Nakanishi A; Shimizu S
    EMBO Rep; 2016 Nov; 17(11):1552-1564. PubMed ID: 27670885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of the ATM/ATR-mediated DNA damage response by the oncogenic phosphatase PPM1D.
    Lu X; Nguyen TA; Donehower LA
    Cell Cycle; 2005 Aug; 4(8):1060-4. PubMed ID: 15970689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Necdin, a p53 target gene, regulates the quiescence and response to genotoxic stress of hematopoietic stem/progenitor cells.
    Asai T; Liu Y; Di Giandomenico S; Bae N; Ndiaye-Lobry D; Deblasio A; Menendez S; Antipin Y; Reva B; Wevrick R; Nimer SD
    Blood; 2012 Aug; 120(8):1601-12. PubMed ID: 22776820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency.
    Kato H; Maezawa Y; Nishijima D; Iwamoto E; Takeda J; Kanamori T; Yamaga M; Mishina T; Takeda Y; Izumi S; Hino Y; Nishi H; Ishiko J; Takeuchi M; Kaneko H; Koshizaka M; Mimura N; Kuzuya M; Sakaida E; Takemoto M; Shiraishi Y; Miyano S; Ogawa S; Iwama A; Sanada M; Yokote K
    Exp Hematol; 2022 May; 109():11-17. PubMed ID: 35240258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rising Prevalence of Low-Frequency
    Seipel K; Veglio NZ; Nilius H; Jeker B; Bacher U; Pabst T
    Curr Issues Mol Biol; 2024 Jul; 46(8):8197-8208. PubMed ID: 39194701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic mosaic truncating mutations of PPM1D in blood can result from expansion of a mutant clone under selective pressure of chemotherapy.
    Kim B; Won D; Lee ST; Choi JR
    PLoS One; 2019; 14(6):e0217521. PubMed ID: 31242196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation.
    Khadka P; Reitman ZJ; Lu S; Buchan G; Gionet G; Dubois F; Carvalho DM; Shih J; Zhang S; Greenwald NF; Zack T; Shapira O; Pelton K; Hartley R; Bear H; Georgis Y; Jarmale S; Melanson R; Bonanno K; Schoolcraft K; Miller PG; Condurat AL; Gonzalez EM; Qian K; Morin E; Langhnoja J; Lupien LE; Rendo V; Digiacomo J; Wang D; Zhou K; Kumbhani R; Guerra Garcia ME; Sinai CE; Becker S; Schneider R; Vogelzang J; Krug K; Goodale A; Abid T; Kalani Z; Piccioni F; Beroukhim R; Persky NS; Root DE; Carcaboso AM; Ebert BL; Fuller C; Babur O; Kieran MW; Jones C; Keshishian H; Ligon KL; Carr SA; Phoenix TN; Bandopadhayay P
    Nat Commun; 2022 Feb; 13(1):604. PubMed ID: 35105861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDK19 regulates the proliferation of hematopoietic stem cells and acute myeloid leukemia cells by suppressing p53-mediated transcription of p21.
    Zhang Z; Lu Y; Qi Y; Xu Y; Wang S; Chen F; Shen M; Chen M; Chen N; Yang L; Chen S; Wang F; Su Y; Hu M; Wang J
    Leukemia; 2022 Apr; 36(4):956-969. PubMed ID: 35110726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal.
    Milyavsky M; Gan OI; Trottier M; Komosa M; Tabach O; Notta F; Lechman E; Hermans KG; Eppert K; Konovalova Z; Ornatsky O; Domany E; Meyn MS; Dick JE
    Cell Stem Cell; 2010 Aug; 7(2):186-97. PubMed ID: 20619763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3.
    Pechackova S; Burdova K; Benada J; Kleiblova P; Jenikova G; Macurek L
    Oncotarget; 2016 Mar; 7(12):14458-75. PubMed ID: 26883108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Ser/Thr phosphatase PPM1D induces neutrophil differentiation in HL-60 cells.
    Kamada R; Kudoh F; Yoshimura F; Tanino K; Sakaguchi K
    J Biochem; 2017 Oct; 162(4):303-308. PubMed ID: 28486685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing of PPM1D inhibits cell proliferation and invasion through the p38 MAPK and p53 signaling pathway in papillary thyroid carcinoma.
    Lu ZW; Wen D; Wei WJ; Han LT; Xiang J; Wang YL; Wang Y; Liao T; Ji QH
    Oncol Rep; 2020 Mar; 43(3):783-794. PubMed ID: 31922231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of p53 in regulation of hematopoiesis in health and disease.
    Barajas S; Cai W; Liu Y
    Curr Opin Hematol; 2022 Jul; 29(4):194-200. PubMed ID: 35787548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A unique role of p53 haploinsufficiency or loss in the development of acute myeloid leukemia with FLT3-ITD mutation.
    Yang M; Pan Z; Huang K; Büsche G; Liu H; Göhring G; Rumpel R; Dittrich-Breiholz O; Talbot S; Scherr M; Chaturvedi A; Eder M; Skokowa J; Zhou J; Welte K; von Neuhoff N; Liu L; Ganser A; Li Z
    Leukemia; 2022 Mar; 36(3):675-686. PubMed ID: 34732858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax.
    Ye S; Xiong F; He X; Yuan Y; Li D; Ye D; Shi L; Lin Z; Zhao M; Feng S; Zhou B; Weng H; Hong L; Ye H; Gao S
    Theranostics; 2023; 13(1):77-94. PubMed ID: 36593968
    [No Abstract]   [Full Text] [Related]  

  • 39. Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice.
    Shing DC; Trubia M; Marchesi F; Radaelli E; Belloni E; Tapinassi C; Scanziani E; Mecucci C; Crescenzi B; Lahortiga I; Odero MD; Zardo G; Gruszka A; Minucci S; Di Fiore PP; Pelicci PG
    J Clin Invest; 2007 Dec; 117(12):3696-707. PubMed ID: 18037989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of O-GlcNAcase Inhibits Hematopoietic and Leukemic Stem Cell Self-Renewal and Drives Dendritic Cell Differentiation via STAT3/5 Signaling.
    Luanpitpong S; Rodboon N; Samart P; Janan M; Klaihmon P; Lorthongpanich C; U-Pratya Y; Issaragrisil S
    Stem Cells; 2022 Dec; 40(12):1078-1093. PubMed ID: 36124999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.